Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergio Valente

Showing results (81-90 of 155) with videos related to

Pageof 16
Sort By:
Stem Cells (Dayton, Ohio)|January 15, 2010
Nitric oxide determines mesodermic differentiation of mouse embryonic stem cells by activating class IIa histone deacetylases: potential therapeutic implications in a mouse model of hindlimb ischemiaFrancesco Spallotta, Jessica Rosati, Stefania Straino, et al.
International Journal of Molecular Sciences|February 26, 2022
Inhibition of PKCθ Improves Dystrophic Heart Phenotype and Function in a Novel Model of DMD CardiomyopathyJacopo Morroni, Leonardo Schirone, Valentina Valenti, et al.
Molecular Pharmacology|August 2, 2007
Identification of two new synthetic histone deacetylase inhibitors that modulate globin gene expression in erythroid cells from healthy donors and patients with thalassemiaAntonello Mai, Katija Jelicic, Dante Rotili, et al.
Journal of Medicinal Chemistry|June 28, 2014
1,3,4-Oxadiazole-containing histone deacetylase inhibitors: anticancer activities in cancer cellsSergio Valente, Daniela Trisciuoglio, Teresa De Luca, et al.
Cells|March 11, 2023
Role of SIRT3 in Microgravity Response: A New Player in Muscle Tissue RecoveryMichele Aventaggiato, Federica Barreca, Laura Vitiello, et al.
Journal of Molecular Endocrinology|July 20, 2010
HDACs class II-selective inhibition alters nuclear receptor-dependent differentiationAngela Nebbioso, Carmela Dell'Aversana, Anne Bugge, et al.
Biochimie|June 20, 2012
Identification of PR-SET7 and EZH2 selective inhibitors inducing cell death in human leukemia U937 cellsSergio Valente, Ilaria Lepore, Carmela Dell'Aversana, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 23, 2022
Heterocycle-containing tranylcypromine derivatives endowed with high anti-LSD1 activityRossella Fioravanti, Veronica Rodriguez, Jonatan Caroli, et al.
Plos Currents|September 30, 2010
Evaluation of histone deacetylases as drug targets in Huntington's disease models. Study of HDACs in brain tissues from R6/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell modelLuisa Quinti, Vanita Chopra, Dante Rotili, et al.
Clinical Epigenetics|December 4, 2019
Dissecting the role of novel EZH2 inhibitors in primary glioblastoma cell cultures: effects on proliferation, epithelial-mesenchymal transition, migration, and on the pro-inflammatory phenotypeGiulia Stazi, Ludovica Taglieri, Alice Nicolai, et al.
Pageof 16

Showing results (81-90 of 155) with videos related to

Sort By:
Pageof 16
Stem Cells (Dayton, Ohio)|January 15, 2010
Nitric oxide determines mesodermic differentiation of mouse embryonic stem cells by activating class IIa histone deacetylases: potential therapeutic implications in a mouse model of hindlimb ischemiaFrancesco Spallotta, Jessica Rosati, Stefania Straino, et al.
International Journal of Molecular Sciences|February 26, 2022
Inhibition of PKCθ Improves Dystrophic Heart Phenotype and Function in a Novel Model of DMD CardiomyopathyJacopo Morroni, Leonardo Schirone, Valentina Valenti, et al.
Molecular Pharmacology|August 2, 2007
Identification of two new synthetic histone deacetylase inhibitors that modulate globin gene expression in erythroid cells from healthy donors and patients with thalassemiaAntonello Mai, Katija Jelicic, Dante Rotili, et al.
Journal of Medicinal Chemistry|June 28, 2014
1,3,4-Oxadiazole-containing histone deacetylase inhibitors: anticancer activities in cancer cellsSergio Valente, Daniela Trisciuoglio, Teresa De Luca, et al.
Cells|March 11, 2023
Role of SIRT3 in Microgravity Response: A New Player in Muscle Tissue RecoveryMichele Aventaggiato, Federica Barreca, Laura Vitiello, et al.
Journal of Molecular Endocrinology|July 20, 2010
HDACs class II-selective inhibition alters nuclear receptor-dependent differentiationAngela Nebbioso, Carmela Dell'Aversana, Anne Bugge, et al.
Biochimie|June 20, 2012
Identification of PR-SET7 and EZH2 selective inhibitors inducing cell death in human leukemia U937 cellsSergio Valente, Ilaria Lepore, Carmela Dell'Aversana, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 23, 2022
Heterocycle-containing tranylcypromine derivatives endowed with high anti-LSD1 activityRossella Fioravanti, Veronica Rodriguez, Jonatan Caroli, et al.
Plos Currents|September 30, 2010
Evaluation of histone deacetylases as drug targets in Huntington's disease models. Study of HDACs in brain tissues from R6/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell modelLuisa Quinti, Vanita Chopra, Dante Rotili, et al.
Clinical Epigenetics|December 4, 2019
Dissecting the role of novel EZH2 inhibitors in primary glioblastoma cell cultures: effects on proliferation, epithelial-mesenchymal transition, migration, and on the pro-inflammatory phenotypeGiulia Stazi, Ludovica Taglieri, Alice Nicolai, et al.
Pageof 16